Participants of PCa19 can expect two days of immersion in all the latest treatment options for prostate cancer, says Prof. Steven Joniau (Leuven, BE), member of the PCa19 Scientific Committee and one of the faculty members. Now in its third edition, EAU Update on Prostate Cancer (which takes place in Prague on the 11th and 12th of October, 2019) is the longest-running flagship of the EAU’s Oncology Update meetings.
Uniquely, registration for PCa19 includes free accommodation in Prague if you book before October 2nd. We spoke to Prof. Joniau about the upcoming meeting, the EAU’s goals for the meeting and the hottest topics that will be discussed this autumn.
This marks the third occasion of the EAU’s PCa update. How do you think this meeting has been received in the past years, and has it developed since its launch?
“The EAU PCa update meetings have a unique, highly interactive format which resembles the EUREP course but is fine-tuned to a more experienced audience. What sets these meetings apart is that they focus uniquely on all aspects of PCa management and may be considered true PCa Master Classes. The past two meetings were very positively received and were attended by 250-300 urologists, radiation oncologists, medical oncologists, onco-nurses, and PCa researchers from all over the world.”
“The format consists of concise, introductory state-of-the art lectures by European key opinion leaders in the main auditorium, followed by interactive case discussions in separate break-out rooms. The faculty members are scored by the attendees and only the highest-scoring faculty are invited for the next meeting! In summary, the EAU’s PCa update meetings are a must for all practitioners dealing with PCa patients.”
At the recent National Societies Meeting in Noordwijk, the EAU reiterated its commitment to familiarising urologists with oncological treatment options and to make sure that urologists remain the primary carer for urological cancer patients. How does PCa19 fit into this strategy?
“As urologists, we are the gatekeeper of every single PCa patient. We follow and guide patients from diagnosis until (sometimes) full-blown metastatic disease and do so as leaders of a multidisciplinary team in which we work closely together with onco-nurses, general practitioners, radiologists, pathologists, radiation oncologists, and medical oncologists. The EAU PCa update meetings perfectly fit in the multidisciplinary care of PCa patients, as experts from all these disciplines are welcome in the faculty as well as in the audience!”
What are some topics that you are looking forward to at PCa19 this year?
“I personally look forward to learning about the latest developments in diagnostic imaging, such as mpMRI and PSMA PET/CT. Another hot item is focal treatment of localised disease and metastasis-directed therapy in oligometastatic disease.”
This meeting is heavily case-based. How do you think participants learn from these?
“A case-based meeting with voting questions and direct interaction with European key opinion leaders is undoubtedly a unique and very practice-based way of learning. The very positive feedback we got from the past two meetings reinforces that this is the best strategy to learn as much as possible in a two-day meeting.”
What do you think participants will be taking away from this meeting? How will they improve as urologists?
“As all lectures and case discussions are built upon the latest EAU Guidelines on PCa, participants will be fully updated on the current developments in diagnosis and treatment of PCa. Undoubtedly, the knowledge gained from the PCa19 Update will help all individual participants in treating their patients in the most up-to-date way.”
Share this on your favourite network: